International Biotechnology Trust’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

International Biotechnology Trust’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,200	Closed	-$296K	–	66
2019 Q4	$296K	Hold	11,200	–	–	0.11%	61
2019 Q3	$255K	Sell	11,200 -134,800	-92%	-$4.25M	0.12%	57
2019 Q2	$4.47M	Buy	146,000 +47,518	+48%	+$1M	1.66%	19
2019 Q1	$1.63M	Buy	+98,482	New	+$1.87M	0.6%	43
2018 Q4	–	Sell	-72,000	Closed	-$2.88M	–	51
2018 Q3	$2.88M	Hold	72,000	–	–	1.37%	25
2018 Q2	$3.12M	Sell	72,000 -31,000	-30%	-$1.33M	1.2%	28
2018 Q1	$3.81M	Buy	103,000 +64,000	+164%	+$1.71M	1.49%	21
2017 Q4	$773K	Hold	39,000	–	–	0.27%	59
2017 Q3	$971K	Buy	+39,000	New	+$720K	0.38%	46

Other funds holding GTHX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

International Biotechnology Trust's GTHX Position: Q1 2020 in Review

International Biotechnology Trust sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2020, closing a stake of 11,200 shares — an estimated $296K sold.

International Biotechnology Trust first reported a position in GTHX in Q3 2017 and held it in 9 quarters. The position peaked at $4.47M in Q2 2019. 100 funds tracked by Wall St. Rank hold GTHX as of Q1 2020.

International Biotechnology Trust reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
International Biotechnology Trust sold 11,200 G1 Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $296K.
International Biotechnology Trust first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
International Biotechnology Trust's G1 Therapeutics, Inc. Common Stock position peaked at $4.47M in Q2 2019.
100 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2020.

Based on International Biotechnology Trust's 13F filing for Q1 2020, filed 18 May 2020.